Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hepatitis c
Phenotype |cirrhosis
Sentences 176
PubMedID- 21687605 Compared the diagnostic accuracy of using 13c-mbt with several noninvasive tests like the apri, aar, and fibroindex and found that the 13c-mbt was more reliable in predicting advanced fibrosis and cirrhosis in patients with chronic hepatitis c [22].
PubMedID- 22628340 Methods: ten patients with cirrhosis due to hepatitis c virus (hcv) infection and without hcc were enrolled in the study.
PubMedID- 25187808 Liver function and liver fibrosis were markedly recovered in hepatitis c patients with hepatic cirrhosis following treatment with the combination treatment compared with those in the patients treated with pegasys alone (p<0.05).
PubMedID- 26513826 [hope for cirrhosis patients with genotype 1 hepatitis c virus who failed the previous treatment].
PubMedID- 24693307 Several studies have investigated the potential usefulness of serum biomarkers of liver function and indices derived from these biomarkers in prediction of liver fibrosis and cirrhosis in patients with hepatitis c and b (7, 17, 19, 24).
PubMedID- 26437001 The aim of this study was to assess the value of measuring wfa+ -csf1r levels for the prognosis of carcinogenesis and outcome in liver cirrhosis (lc) patients with hepatitis c virus (hcv).
PubMedID- 20217081 Hepatocellular carcinoma (hcc) occurs most commonly secondary to cirrhosis due to chronic hepatitis c or b virus (hcv/hbv) infections.
PubMedID- 26504882 A 56-year-old woman with cirrhosis due to chronic hepatitis c underwent esophagogastroduodenoscopy (egd) for evaluation and banding of esophageal varices.
PubMedID- 24564861 For the cirrhosis group, patients with hepatitis c and biopsy proven cirrhosis were enrolled.
PubMedID- 20497143 Systematic review: outcome of compensated cirrhosis due to chronic hepatitis c infection.
PubMedID- 23849467 The present cross-sectional study investigated 12 perfluoroalkyl substances (pfass) in serum (n=79) and liver (n=66) samples from patients who had undergone liver transplantation for a range of conditions, such as hepatocellular carcinoma (hcc), cirrhosis due to chronic hepatitis c viral infection (hcv), both hcc and hcv, amyloidosis or acute liver failure.
PubMedID- 25103219 Background: the hepatitis c virus may lead to cirrhosis, liver cancer, liver transplant, and increased mortality.
PubMedID- 24281168 Plasma ykl-40 predict cirrhosis (ishak 5/6) in patients with chronic hepatitis c, but was not included in the final three-variable model consisting of serum hyaluronan, tissue inhibitor of metalloprotinases (timp)-1 and platelet count [171,172].
PubMedID- 21507271 Hepatocellular carcinoma and hepatic cirrhosis are consequences of chronic hepatitis c. the mean infection time to onset of cirrhosis is approximately 30 years, but cirrhosis may occur within a range of 10-50 years [20].
PubMedID- 19935643 Chronic hepatitis c viral infection can lead to cirrhosis and hepatocellular carcinoma.
PubMedID- 21221473 Conclusion: patients with cirrhosis due to hepatitis c virus who achieved sustained virological response had significantly lower incidence of hepatocellular carcinoma when compared to those without treatment response.
PubMedID- 20811639 For the cirrhosis group, patients with hepatitis c and biopsy-proven cirrhosis were enrolled.
PubMedID- 22087085 A 68-year-old woman with large gastric varices caused by liver cirrhosis associated with hepatitis c, which were in danger of rupture, was admitted to our hospital for brto.
PubMedID- 21324927 A 52-yr-old man with uncompensated cirrhosis due to hepatitis c received an ldlt from his healthy daughter.
PubMedID- 24229036 A 60-year-old woman was referred for living donor liver transplant because of liver cirrhosis due to hepatitis c.
PubMedID- 20426802 Once developed, 30% to 40% of these patients succumb a liver-related death over a 10-year period [51,52], a mortality rate similar to[53,54] or worse than cirrhosis associated with hepatitis c. nash-associated cirrhosis can also develop into into a subacute liver failure, or progress to hepatocellular cancer [55], as well as reoccur after liver transplantation.
PubMedID- 23139898 In fact, the proportion of chronic hepatitis c patients with cirrhosis is expected to reach 25% in 2010 and 45% in 2030 (davis et al.
PubMedID- 20964825 Tlr4 was identified as one of seven genes associated with increased risk of developing cirrhosis in patients with chronic hepatitis c [72,121].
PubMedID- 22121492 A platelet count <160,000 × 10(9)/l is 80% sensitive in detecting portal hypertension from cirrhosis in patients with chronic hepatitis c [5].
PubMedID- 22792259 Hepatocellular carcinoma is frequently associated with advanced cirrhosis due to chronic hepatitis c. progressive liver damage until hcc development in chronic hcv-infected patients encompasses deregulation of molecular pathways triggering malignant transformation.
PubMedID- 26486859 Impact of liver cirrhosis due to chronic hepatitis c viral infection on the outcome of ovarian cancer: a prospective study.
PubMedID- 24156952 In asymptomatic naive patients, cart is recommended if the cd4(+) lymphocyte count is <500cells/mul; if the cd4(+) lymphocyte count is >500cells/mul, cart can be delayed, although it may be considered in patients with liver cirrhosis, chronic infection due to hepatitis c virus, high cardiovascular risk, plasma viral load (pvl) >10(5)copies/ml, cd4(+) lymphocyte percentage <14%, cognitive impairment, and age >55 years.
PubMedID- 24424890 Macrophage-related serum biomarkers soluble cd163 (scd163) and soluble mannose receptor (smr) to differentiate mild liver fibrosis from cirrhosis in patients with chronic hepatitis c: a pilot study.
PubMedID- 22742057 Patients infected with hepatitis b or patients with cirrhosis due to hepatitis c virus infection, alcohol abuse or another cause are patients at risk for the development of hcc.
PubMedID- 24976280 Egy-score showed good sensitivity, specificity, positive and negative predictive values, and over all accuracy for detecting different stages of hepatic fibrosis and cirrhosis in patients with chronic hepatitis c.
PubMedID- 25803885 A 33-year-old japanese man who had suffered from liver cirrhosis due to hepatitis c virus (hcv) underwent living related liver transplantation (lrlt).
PubMedID- 24524410 Previously reported that serum levels of the aim protein were elevated in hepatitis c patients with liver cirrhosis compared to healthy controls, using a proteomics method based on 2-dimensional gel electrophoresis (2-de)[22].
PubMedID- 23300494 Patients and methods: ninety patients were enrolled: 30 cases of chronic hepatitis c (chc) without cirrhosis, 30 cases of chc with liver cirrhosis, and 30 cases of hcc and hepatitis v virus (hcv) infection.
PubMedID- 23317427 Methods: all consecutive japanese patients with hepatic cirrhosis due to hepatitis c who had undergone elective splenectomy in kyushu university hospital between january 2008 and december 2009 were included in this retrospective study.
PubMedID- 25074044 Methods: we describe a patient with decompensated cirrhosis because of severe recurrent hepatitis c, who had a retransplant following treatment with a combination of sofosbuvir and riba virin that started during the waiting time and was carried over during both the transplant and post-transplant phases for an overall period of 24 weeks.
PubMedID- 21330908 The natural history of liver cirrhosis in hiv-hepatitis c virus-coinfected patients.
PubMedID- 22464782 Forty-nine hepatitis c patients with liver cirrhosis who were unable to use antiviral therapy because of hypersplenism were recruited for study and treated with splenectomy or partial splenic embolization.
PubMedID- 26176835 cirrhosis due to hepatitis c infection is the leading indication for liver transplantation worldwide.
PubMedID- 21359205 Liver explant pathological specimens from patients undergoing liver transplantation for chronic hepatitis c with cirrhosis (n = 7) and unused donor (control) liver tissue (n = 10) were collected with irb approval.
PubMedID- 19242795 Previous studies have, however, included mostly patients with cirrhosis due to hepatitis c.
PubMedID- 21079746 Chronic hepatitis c (chc) may lead to liver cirrhosis and hepatocellular carcinoma.
PubMedID- 24378262 Anti-hbc positivity was associated with histological cirrhosis in patients with chronic hepatitis c.
PubMedID- 24766091 Background & aims: chronic hepatitis c may be associated with cirrhosis, liver failure and hepatocellular carcinoma.
PubMedID- 25944238 Treatment options for chronic hepatitis c in patients with decompensated cirrhosis and end-stage renal disease will also be discussed.
PubMedID- 24603710 Most patients had liver cirrhosis (90%); mainly due to chronic hepatitis c infection; and 40% had ascites.
PubMedID- 22661952 Evidence from a large patient cohort demonstrated that the tlr4 single nucleotide polymorphisms (snps) reduces the risk of liver cirrhosis in patients with chronic hepatitis c (huang et al., 2007).
PubMedID- 24627800 Unfortunately, our patient had untreated cirrhosis due to hepatitis c and alcohol misuse, and had continued to consume alcohol up until the day of admission, and was deemed a poor surgical candidate.
PubMedID- 21526140 Transient elastography has also been demonstrated to be a reliable tool for assessing fibrosis and cirrhosis mainly in patients with chronic hepatitis c (chc) [5, 6].
PubMedID- 23762271 hepatitis c virus (hcv) is the main causative agent of acute and chronic non-a, non-b hepatitis and may lead to liver cirrhosis and hepatocellular carcinoma (hcc).
PubMedID- 25713606 The guidelines make a strong statement that patients with cirrhosis due to hepatitis c, cirrhosis due to alcohol, and cirrhosis due to other causes need to undergo screening and surveillance as well.

Page: 1 2 3 4